| Ytd | 85.74% | |
| 1y | 58.34% |
| Open | 53.72 | Prev Close | 53.34 | Low | 53.36 | High | 55.46 | Mkt Cap | 8.48B |
| Vol | 1.62M | Avg Vol | 2.01M | EPS | 2.75 | P/E | 20.13 | Forward P/E | 20.45 |
| Beta | 1.80 | Short Ratio | 16.80 | Inst. Own | 74.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-02 | 50-d Avg | 53.55 | 200-d Avg | 41.76 | 1yr Est | 69.71 |
TGTX News
NEW YORK--(BUSINESS WIRE)---- $TGTX--TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the sched
TG Therapeutics, Inc. (NASDAQ: TGTX - Get Free Report) shares passed above its 200-day moving averag
NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inve
Puma Biotechnology (NASDAQ: PBYI - Get Free Report) and TG Therapeutics (NASDAQ: TGTX - Get Free Rep
B. Riley sees 40+ biotech catalysts ahead as rising rates pressure XBI, setting up a key test for th
TG Therapeutics NASDAQ: TGTX Chairman, President and Chief Executive Officer Mike Weiss said the com
California State Teachers Retirement System lifted its holdings in shares of TG Therapeutics, Inc. (
Fireside chat scheduled for Monday, September 14, 2026, at 12:00pm ET Fireside chat scheduled for Mo
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced th
TG Therapeutics (TGTX) reported earnings 30 days ago. What's next for the stock?
HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy
TG Therapeutics, Inc.'s Q4 2026/H1 2027 will be rich in catalysts. From the presentation of prelimin
Deutsche Bank AG purchased a new stake in TG Therapeutics, Inc. (NASDAQ: TGTX) in the undefined quar
Shares of TG Therapeutics rose this week after buyout rumors surfaced. TG is a prime takeover target
Dow Jones index gained around 350 points on Friday. MARA Holdings Inc (NASDAQ: MARA) rose sharply, w
Bank of America Corp DE lifted its position in TG Therapeutics, Inc. (NASDAQ: TGTX) by 71.7% in the
Assenagon Asset Management S.A. decreased its holdings in shares of TG Therapeutics, Inc. (NASDAQ: T
TG Therapeutics, Inc. (NASDAQ: TGTX - Get Free Report) has earned an average rating of "Hold" from t
JP Morgan analyst Brian Cheng maintains TG Therapeutics (NASDAQ:TGTX) with a Overweight and raise
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its nove
Empowered Funds LLC lifted its position in TG Therapeutics, Inc. (NASDAQ: TGTX) by 49.9% in the unde
TG Therapeutics, Inc. remains a Buy as BRIUMVI's momentum supports a durable, growing multiple scler
TG Therapeutics misses Q2 earnings estimates, but surging Briumvi demand lifts revenues y/y and prom
TG Therapeutics, Inc. (TGTX) Q2 2026 Earnings Call Transcript
TG Therapeutics (NASDAQ:TGTX) raises FY2026 sales outlook from $925.000 million to $950.000 million
TG Therapeutics (NASDAQ:TGTX) reported quarterly earnings of $0.05 per share which missed the analys
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, b
US stocks down, Dow Jones fell 150 pts on Wed. Caseys General Stores Inc (CASY) shares up 14.4% afte
Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY
https://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/october-december-2025-new-safety-
Precision BioSciences, Inc. (NASDAQ:DTIL), a clinical stage gene editing company utilizing its novel
TCOM: -11% | Trip.com Group shares are trading lower after the company announce it is under investig
Retail investors are preparing for another busy week of earnings season with more than 1,600 compani
Top mid-cap stocks jumped up to 23.87%. Some reasons include strong gold/silver, better financial re